FOXO4-DRI mastery course
Unit 8 of 11

Research frontiers & the road to trials

A striking preclinical result is the start of a very long road, not the end. Turning FOXO4-DRI into an approved therapy…

From a mouse paper to a medicine, if it ever gets there

A striking preclinical result is the start of a very long road, not the end. Turning FOXO4-DRI into an approved therapy would require next-generation molecules, a first human trial in the right population, human pharmacokinetics, and a manufacturing process that does not cost a fortune. This unit maps that road and the gaps along it.

It also gives you a durable tool: a way to judge the next FOXO4-DRI headline that appears, because new papers will keep coming.

Key terms

Where FOXO4-DRI sits on the evidence ladder


Cleara and the next-generation peptides


How a first trial might be designed


The gaps, listed plainly


How to judge the next headline